Diagnosis is just the beginning of the battle

The UK lags behind other countries in getting the right treatments to rare disease patients, but promising developments are underway in a bid to help improve access

Why buyers’ clubs are the last option for desperate families

How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK

Why are orphan drugs so expensive?

Current methods to determine the right value for orphan drugs remain controversial, yet the fast-tracking of new therapies marks a big step forward for the industry

Why we still don’t understand chronic pain

Chronic pain is on the rise, and yet there is still no silver bullet to treat this little-understood area of healthcare

Why won’t doctors prescribe medical cannabis?

illustration man reaching for cannabis leaf

Despite last year’s change in the law legalising the supply of medical cannabis, NHS patients in need are still being refused prescriptions

How online pharmacies are improving patients’ lives

Pharmacists are becoming the first port of call for patients with minor illnesses as internet pharmacies take a greater share of dispensing drugs and GPs complain of increasing pressure

What are biosimilars and what can they do?

Manufactured when an original biologic drug’s patent expires, biosimilars can increase access to treatment options and improve patient outcomes

How pharmacies can tackle fake medicines

Regulation targeting fake medicines could speed up the adoption of technology in pharmacies